Biomedicines

Biomedicines (ISSN 2227-9059) is a peer-reviewed, open-access journal published by MDPI that serves as a broad platform for the dissemination of cutting-edge research at the intersection of basic biomedical science and clinical application. The journal’s scope encompasses a wide range of disciplines, including molecular and cellular biology, genetics, immunology, pharmacology, and pathophysiology, with a particular emphasis on understanding disease mechanisms and translating these insights into diagnostic and therapeutic strategies. It welcomes original research articles, comprehensive reviews, and short communications that offer significant contributions to the understanding, prevention, diagnosis, and treatment of human diseases. The target audience includes academic researchers, clinicians, pharmacologists, and graduate students seeking timely, high-quality findings in translational medicine. As an open-access journal, all articles are freely accessible online immediately upon publication, ensuring broad visibility and rapid dissemination of knowledge. Published under the MDPI imprint, Biomedicines adheres to rigorous peer review standards and offers efficient publication processes. With a 2026 Journal Impact Factor of 4.7570, the journal holds a Q2 ranking in the JCR quartile, placing it in the upper half of journals within its multidisciplinary biomedical category. This impact factor and quartile position reflect its solid standing as a reputable venue for impactful preclinical and translational research, making it a competitive choice for authors seeking broad international readership and credible indexing in major databases.